Read the original article on Purewow. The serum is made for all skin types and claims to offer antioxidant, anti-inflammatory and anti-aging benefits that leave complexions bright and glowy. Indeed, ...

Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today reported financial results for the second quarter and six months ended June 30, ...

LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, has been honored with two Beauty Choice Awards from ...

Vitamin C, a powerhouse in the world of skincare, has long been revered for its multiple skin-enhancing properties. This essential nutrient, known scientifically as ascorbic acid, is not just a vital ...

LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin-health systems, announces the launch of Obagi Hydrate. This new ...

Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), ...

Valeant Pharmaceuticals International is to acquire all of the outstanding common stock of Obagi Medical Products for $19.75 per share in cash, which represents a 28 percent premium to Obagi’s closing ...

Obagi Medical Products, Inc. and Valeant Pharmaceuticals, Inc. Agree on an Increased Offer Price of $24.00 per Share in Cash The Obagi Board of Directors unanimously approved the amended transaction ...

Deal sits at $19.75 per share, a 28% premium to yesterday's close. Valeant, which specializes in products designed for dermatology, neurology, and branded generics, has signed a definitive agreement ...

The offer price represents a 28% premium to Obagi's closing share price on Mar 19, 2013. Valeant Pharma expects to close the transaction, which has been approved by Obagi’s board, in the first half of ...